K v1.5 expression and function are decreased in patients having idiopathic pulmonary arterial hypertension 14 and have been implicated in the mechanism of PH associated with hypoxemia. 9, 10, 15 Although Kv 1.5 channel dysfunction is a provocative hypothesis underlying at least some forms of PH, mice lacking Kv 1.5 channels demonstrated normal lung perfusion pressures compared with wildtype controls, without evidence for PH. 13 Thus, dysfunctional or downregulation of Kv 1.5 may be involved with the pathophysiology of some groups of PH, but cannot completely explain the underlying mechanism.
P ulmonary hypertension (PH) is a pathological lung condition that occurs because of vascular remodeling. Although normal mean pulmonary arterial pressure varies from 10 to 20 mm Hg, PH is defined as mean pulmonary arterial pressure ≥25 mm Hg.
1,2 Although the precise incidence and prevalence of PH is uncertain and underestimated, it is being diagnosed at an increasing rate. 3 The World Health Organization has stratified PH into 5 major groups based on the genetic, environmental, and pathogenic triggers. 4 Although the underlying mechanisms may be different, increased pulmonary vascular resistance resulting from a combination of sustained vasoconstriction, thrombosis, inflammation leading to pulmonary vascular remodeling is common to all groups. [5] [6] [7] An important consequence of PH is an increase in right ventricular afterload which, over time, leads to right ventricular hypertrophy, right heart failure, and ultimately death. 1, 8 One of several hypotheses to explain PH involves dysfunction or downregulation of potassium (K + ) channels in the pulmonary circulation. 9 K + channels regulate a number of cellular functions that possibly contribute to the development of PH. 10 In particular, K + channels function to regulate membrane potential in pulmonary vascular smooth muscle cells. When K + channels open during normal physiological conditions, K + moves along its electrochemical gradient from the cytoplasmic space to the extracellular space. The efflux of positive K + ions results in a more hyperpolarized membrane potential. When K + channels close, become dysfunctional, or their expression is downregulated, the cell depolarizes and intracellular Ca 2+ increases as a result of voltage-dependent calcium channel activation. Because intracellular free Ca 2+ is a second messenger for smooth muscle contraction, K + channel dysfunction can result in heightened constriction of pulmonary arteries, leading to increased pulmonary vascular resistance. 10 Two families of K + channels, voltage-activated K + (K v ), and 2-pore domain (K 2P ) have been implicated in PH. Of the K v channels that are responsible for setting the membrane potential of PAMSCs, K v1.5 and K v2.1 are of significance because they inactivate with decreases in O 2 tension. 9, 11, 12 During hypoxic episodes, inactivation of these K v channels produce depolarization to contract pulmonary vascular smooth muscle as described earlier. Absence of the K v1.5 channels in mice lead to impaired vasoconstrictive responses to hypoxia. 13 Furthermore, Abstract-TWIK-2 (KCNK6) is a member of the 2-pore domain (K 2P ) family of potassium channels, which are highly expressed in the vascular system. We tested the hypothesis that TWIK-2 deficiency leads to pulmonary hypertension. TWIK-2 knockout mice and their wildtype littermates at 8 weeks of age had similar mean right ventricular systolic pressures (24±3 and 21±3 mm Hg, respectively.) Significantly, by 20 weeks of age, the mean right ventricular systolic pressures in TWIK-2 knockout mice increased to 35±3 mm Hg (P≤0.036), whereas mean right ventricular systolic pressures in wildtype littermates remained at 22±3 mm Hg. Elevated mean right ventricular systolic pressures in the TWIK-2 knockout mice was accompanied by pulmonary vascular remodeling as determined by a 25% increase in the cross-sectional area of the vessels occupied by the vessel wall. Additionally, secondary branches of the pulmonary artery from 20-week-old TWIK-2 knockout mice showed an enhanced contractile response to U46619 (10 -6 moles/L), a thromboxane A2 mimetic, which was completely abolished with the Rho-kinase inhibitor, Y27632 (10 -6 and 10 -5 moles/L). Treatment of TWIK-2 knockout mice with the Rho-kinase inhibitor, fasudil, in the drinking water for 12 weeks, abolished the development of pulmonary hypertension and attenuated the vessel remodeling. We concluded that mice deficient in the TWIK-2 channel develop pulmonary hypertension between 8 and 20 weeks of age through a mechanism involving Rho-kinase. Our results suggest that downregulation of TWIK-2 in the pulmonary vasculature may be an underlying mechanism in the development of
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K v1.5 expression and function are decreased in patients having idiopathic pulmonary arterial hypertension 14 and have been implicated in the mechanism of PH associated with hypoxemia. 9, 10, 15 Although Kv 1.5 channel dysfunction is a provocative hypothesis underlying at least some forms of PH, mice lacking Kv 1.5 channels demonstrated normal lung perfusion pressures compared with wildtype controls, without evidence for PH. 13 Thus, dysfunctional or downregulation of Kv 1.5 may be involved with the pathophysiology of some groups of PH, but cannot completely explain the underlying mechanism.
In addition to the K v channel family, members of the K 2P family, TASK-1 (KCNK3) and TREK-1 (KCNK2), have also been implicated in the regulation of pulmonary vascular resistance and the possible development of PH. [16] [17] [18] [19] Recently, missense mutations in TASK-1 were identified as possible gene candidates causing idiopathic pulmonary arterial hypertension and familial PH. 17 Alternatively, 1 study presented evidence against the involvement of TASK-1 dysfunction as a cause of PH in mice but left open the possibility that TASK-1 could be involved with PH in other species. 20 Regardless of the evidence for and against TREK-1 and TASK-1 as the underlying mechanism for PH in mice, direct measurements of pulmonary arterial pressure (or its surrogate right ventricular pressure), the standard for diagnosing PH, have not been reported in mice lacking these K 2P channels.
TWIK-2 (KCNK6), another member of the K 2P family, is also expressed in the vascular system. Of the 15 known members of the K 2P family, TREK-1, TASK-1, and TWIK-2 show the greatest levels of expression for K 2P in the vascular system. [21] [22] [23] Recently, our laboratory reported that mice lacking TWIK-2 are hypertensive at 8 weeks of age and have an altered contractile response in isolated aortic ring segments. 24 Given the importance of TWIK-2 in the systemic circulation, we questioned whether it has a similar role in the pulmonary circulation. We hypothesized that (i) TWIK-2 is involved with regulating pulmonary vascular tone and (ii) TWIK-2 dysfunction in the pulmonary circulation leads to PH. After our initial results showed that TWIK-2 knockout mice develop PH and that branches of the pulmonary artery are hypercontractile to a thromboxane A2 mimetic, we sought to determine the mechanism involved with the onset of PH in TWIK-2 knockout mice.
Because Rho-kinase promotes contraction of vascular smooth muscle cells by inhibiting the dephosphorylation of myosin light chain, we tested the hypothesis that (iii) inhibition of Rhokinase in mice lacking TWIK-2 attenuates hypercontractility of the pulmonary arteries and attenuates the development of PH.
Results

TWIK-2 Expression in Lung Tissue and Pulmonary Vessels From Wildtype Mice
TWIK-2 is expressed in the pulmonary artery and first-order branches and lung tissue from 20-week-old male knockout and wildtype mice ( Figure S1A and S1B in the online-only Data Supplement). K v 1.5 and TASK-1 were included because they relate to previous studies involving PH. 9, 13, 16, 17 Expression of TWIK-2 (P<0.05; n=7) was absent in the knockout, whereas expression of K V 1.5 and TASK-1 was unaltered compared with the wildtype mice.
Mice Lacking TWIK-2 Develop PH and Pulmonary Vascular Remodeling
Right ventricular systolic pressure (RVSP), a surrogate measure of pulmonary pressures, 25 was measured in TWIK-2 knockout male mice and wildtype male littermates ( Figure 1A ). Figure 1C shows hematoxylin and eosin staining (top panels) and immunostaining of smooth muscle α-actin (bottom panels) from lung sections of 20-week-old TWIK-2 knockout mice and their wildtype littermates. Note the increase in wall thickness (arrows) in lung vessels from TWIK-2 knockout mice compared with wildtype mice (Figure 1C, top) . Figure 1C (bottom) demonstrates that the vessel wall (arrows in the top 2 panels) consists of vascular smooth muscle (red in the image). Figure 1B shows the percent of the cross-sectional Note that the percent area occupied by the vessel wall is significantly increased in the pulmonary vessels of 20-weekold, but not 8-week-old TWIK-2 knockout mice. Although the results in Figure 1B were derived from the hematoxylin and eosin-stained images, similar results were obtained when measurements were made using the immunohistochemical images of smooth muscle α-actin (data not shown). The vascular remodeling seemed to correlate with the increase in mean RVSP Figures 1A and 1B) .
Mice Lacking TWIK-2 Have an Increased Right Ventricular End-Diastolic Volume, But No Alterations in Left Ventricular Size or Function
During the development of PH, right ventricular end-diastolic volume is often increased initially as a result of a pressure overload 2,25,26 followed later by a decrease in right ventricle ejection fraction (EF%) as the right ventricle remodels to the pressure overload. Figure S2A shows that 20-week-old TWIK-2 knockout mice have an increased right ventricular end-diastolic volume (P=0.02, n=4) when compared with their wildtype littermate controls. Representative MRI images of the right ventricle at end diastole in a wildtype and a TWIK-2 knockout mouse is shown in Figure S2E . Right ventricular contractility, as measured by the ejection fraction, was not altered in TWIK-2 knockout mice compared with wildtype littermates ( Figure S2B) .
Given that the TWIK-2 knockout mice have increased systemic blood pressures, 24 it was important to determine whether increased mean RVSP was related to the systemic hypertension. With systemic hypertension, the increase in right ventricular pressures could result indirectly from left ventricular dysfunction or increased left ventricular filling pressures. Figure S2C and S2D shows left ventricular end-diastolic volume and ejection fraction (EF%) in 20-week-old TWIK-2 knockout mice. There were no significant differences in either when compared with wildtype littermates. Furthermore, the left ventricular wall thickness was not significantly different in the wildtype and TWIK-2 knockout mice. At its widest point, the ratio of the left ventricle wall to the total cross-sectional area of the left ventricle was 0.50±0.05 and 0.53±0.06 (P=0.66, n=4 each group) in TWIK-2 knockout mice and their wildtype littermates, respectively. An additional consideration is that systemic hypertension can lead to elevated left ventricular end diastolic pressures, which could be a cause of PH in the TWIK-2 knockout mice. We found no significant increase in the left ventricular end-diastolic pressures of 18-to 22-week-old TWIK-2 knockout and wildtype mice (data not shown).
TWIK-2 Knockout Mice Pulmonary Arteries Are Hypercontractile to a Thromboxane A2 Mimetic Through Activation of Rho-Kinase
Isometric contractions to phenylephrine, an α-adrenoreceptor agonist, or U46619, a thromboxane A2 (TXA 2 ) mimetic, were measured in rings of first-order branches of pulmonary arteries from 20-week-old TWIK-2 knockout mice and their wildtype littermates (Figure 2A and 2B) . Although the contractile responses to phenylephrine were similar between genotype, the response to U46619 was increased at a concentration of 10 -6 mol/L (P=0.04, n=8 each group) in arterial rings from TWIK-2 knockout compared with that observed in arterial rings from wildtype mice. In addition, contractile responses to 60 mmol/L KCl (n=9) were similar between rings of the firstorder branches of pulmonary arteries from TWIK-2 knockout mice and their wildtype littermates (data not shown).
Because stimulation of the TXA 2 receptor can activate downstream rho-kinase signaling, we determined whether the enhanced contractile response to U46619 could be blocked by inhibition of Rho-kinase. Figure 2C shows the contractile responses to a single dose of 10 -6 mol/L U46619 in arterial rings from 20-week-old wildtype and TWIK-2 knockout mice in the absence and presence of the Rho-kinase inhibitor, Y27632 (10 -6 and 10 -5 moles/L). Y27632 had no significant effects on the force generated in ring from wildtype mice; however, it significantly attenuated the contractile response in a dose-dependent manner in pulmonary artery rings from TWIK-2 knockout mice. With Y27632 pretreatment, the contractile responses to 10 -6 mol/L U46619 were decreased to levels in rings from wildtype mice. Thus, it seems that Rho-kinase activity was responsible for the hypercontractile response to U46619 in first-order branches of the pulmonary artery in TWIK-2 knockout mice. 
Treatment With a Rho-Kinase Inhibitor Reduced RVSP and Pulmonary Vascular Remodeling in TWIK-2 Knockout Mice
Having demonstrated enhanced contractility with Rho-kinase activation in first-order branches of pulmonary arteries and increased Rho-kinase activity in whole lungs from 20-weekold TWIK-2 knockout mice, we determined whether inhibition of Rho-kinase in vivo could be an effective treatment for the hypertension that develops between 8 and 20 weeks in TWIK-2 knockout mice. Eight-week-old TWIK-2 knockout mice and wildtype littermates were provided with regular drinking water or drinking water with 1 mg/mL fasudil, a Rho-kinase inhibitor. Fasudil was used for these studies because it has been demonstrated as an effective inhibitor of Rho-kinase when administered orally. 27 At 20 weeks of age, mean RVSP was measured by right heart catheterization, and lungs were harvested for histological analysis. Fasudil treatment abolished the increase in mean right ventricular pressure in TWIK-2 knockout mice ( Figure 3A ) and diminished pulmonary vascular remodeling. Figure 3B shows that fasudil treatment in the TWIK-2 knockout mice attenuated vessel remodeling as determined by the percent of the cross-sectional area in lung vessels occupied by the vessel wall. Figure  S3 shows hematoxylin and eosin-stained lung sections with the arrow pointing to the arterial wall. Thus, the development of PH in TWIK-2 knockout mice seems to be mediated by the Rho-kinase pathway and can be attenuated by Rho-kinase inhibition.
Discussion
The results of our study demonstrate that loss of function of the 2-pore domain K + channel, TWIK-2, produces PH. Given the importance of the TWIK-2 channel, in the systemic circulation, 24 we questioned whether it has a similar role in the pulmonary circulation. Consistent with previous studies conducted in multiple species, 21, [28] [29] [30] we report that TWIK-2 is expressed in the lung and pulmonary circulation of mice ( Figure S1 ). By using a TWIK-2 knockout mouse in the present study, we conclude the following: (i) loss of function of TWIK-2 in the pulmonary circulation leads to the development of PH ( Figure 1A and 3A) and vascular wall remodeling ( Figures 1B, 1C , and 3B and Figure S3 ), (ii) PH and remodeling occur between 8 and 20 weeks of age in the TWIK-2 knockout mice, (iii) the mechanism of this PH phenotype seems possibly mediated by hypercontractility as a result Rho-kinase pathway activation (Figure 2) , and (iv) treatment of TWIK-2 knockout mice with a Rho-kinase inhibitor before the onset of PH significantly attenuates pulmonary arterial pressures ( Figure 3A ) and vascular remodeling ( Figure 3B and Figure S3 ). Our studies suggest that TWIK-2 regulates pulmonary vascular tone by inhibiting the activity and expression of Rho-kinase.
Although decreased K + channel activity has been hypothesized to underlie the development of PH, the TWIK-2 knockout model is the first K2P
+ channel knockout mouse model, to our knowledge, known to develop PH. A recent study reported the important link between the missense mutation of another member of the 2-pore domain K + channel family, TASK-1 or KCNK3, and a familial form of human PH. 17 Given that the pulmonary circulation express a number of 2-pore domain K + channels 18, 21 and that 2 members of this family have been implicated with PH to date (present study included), it is reasonable to consider that dysfunction of other members of this family could also result in PH.
One potential confounding factor involved with our model of PH is the systemic hypertension, which is present by 8 weeks of age in TWIK-2 knockout mice. 24 Because the pulmonary and systemic circulations function at independent pressures, PH should be secondary to systemic hypertension only when there is dysfunction in the left side of the heart (classified as World Health Organization Group 2 PAH). We measured left ventricular function and morphology in TWIK-2 knockout mice at 20 weeks of age, a time when PH was fully developed. Our studies demonstrate that left ventricular end-diastolic volume and ejection fraction were similar in 20-week-old TWIK-2 knockout mice and their wildtype littermates ( Figure 2C and  2D) . Furthermore, we found no indication of left ventricular remodeling as determined by wall thickness in the TWIK-2 knockout mice at 20 weeks of age (see results) and no changes in left ventricular pressures as measured by left cardiac catheterization (see Methods and Supplementary materials). Thus, we conclude that PH, developing between the ages of 8 and 20 weeks in male TWIK-2 knockout mice, is not a result of left-sided heart failure. Instead, our model confers a unique hypertensive phenotype in the pulmonary vasculature resulting from TWIK-2 dysfunction in the pulmonary vessels. 
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Our studies demonstrate a potentially important role for Rho-kinase in the development of PH in male TWIK-2 knockout mice. Rho-kinase, through its inhibition of myosin light chain phosphatase, helps to maintain a contracted state in vascular smooth muscle by preventing the dephosphorylation of myosin light chain. 31 Additionally, Rho-kinase is involved with remodeling in the vessel wall, in part, through enhancing vascular smooth muscle motility and smooth muscle proliferation. 31, 32 At the arterial level, Rho-kinase activity was enhanced in the TWIK-2 knockout mice and seems to be at least partially responsible for PH in the TWIK-2 knockout mice by increasing pulmonary vascular resistance through alterations in arterial contractility. A recent publication addressed the complexity of the varying factors involved in pulmonary vasoconstriction and remodeling, including the contributions of hypoxia. 33 Although we do not believe Rho-kinase activation is the only mechanism behind TWIK-2 deficiency leading to hypercontractility, the interactions between TWIK-2 and Rho-kinase signaling and their combined roles in intracellular calcium homeostasis are potentially revealing and require further study. Enhanced Rho-kinase activity is commonly associated with cardiovascular diseases, in general, including other forms of PH. 32, 34 For example, long-term inhibition of rho-kinase attenuated chronic hypoxia-and monocrotaline-induced PH in rodents. [34] [35] [36] In addition, fasudil acutely decreased pulmonary vascular resistance in humans with PH, although mean pulmonary arterial pressure only slightly decreased (≈3 mm Hg) in 1 study 37 and was not significantly affected in another. 38 It is reasonable to consider that pulmonary artery vascular smooth muscle cells in TWIK-2 knockout mice are more depolarized and have an increase in intracellular-free Ca 2+ compared with that in wildtype mice. 24 Because K + channels function to regulate membrane potential in pulmonary vascular smooth muscle cells, 9, 11, 12 loss of function of TWIK-2 should depolarize the vascular smooth muscle and increase intracellular Ca 2+ through activation of voltage-dependent calcium channels. The depolarization and increased Ca 2+ in pulmonary vascular smooth muscle cells could produce PH through 2 possible mechanisms. First, intracellular-free Ca 2+ is a second messenger for smooth muscle cell contraction. With an increase in intracellular Ca 2+ resulting from the loss of TWIK-2, a persistent increase in the contractile state of pulmonary arteries and arterioles would serve to increase the pulmonary vascular resistance. Second, both membrane depolarization and increased cytoplasmic Ca 2+ are stimuli that activate Rhokinase. [39] [40] [41] Activation of Rho-kinase would both increase the sensitivity of the contractile machinery in the vascular smooth muscle to Ca 2+ and stimulate vessel remodeling.
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Perspectives
This study is the first to demonstrate a role for the TWIK-2 K + channel in the regulation of pulmonary vascular tone. The observation that male TWIK-2 knockout mice spontaneously develop PH between 8 and 20 weeks of age makes the PH phenotype more physiological and comparable to human disease compared with other drug-induced models of PH. Of significance, the increase in right ventricular end diastolic volume seen in the TWIK-2 knockout mice parallel the increase in right ventricular end diastolic volume without right ventricular remodeling that occurs during the early stages of PH in humans. 4, 25 The presence of right ventricular dilatation is notable because deaths and clinical deterioration in PH are directly related to alterations in right heart pressures and remodeling. 1, 3 We describe a potential role for enhanced Rho-kinase activity in the development of PH in the TWIK-2 knockout mice by increasing pulmonary vascular resistance through alterations in arterial contractility and by vascular remodeling. Given the recently described role of another K 2P channel in human PH, 17 TWIK-2 dysfunction could be important in the pathogenesis of human PH through either a loss of function mutation in familial forms of PH or by downregulation of TWIK-2 from environmental factors (such as hypoxia) in other forms of PH.
